Alzamend Neuro, Inc.

0.87 USD
-0.02 (-2.71%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Alzamend Neuro, Inc. stock is down -0.94% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 February’s closed higher than January.

About Alzamend Neuro, Inc.

Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative diseases and psychiatric disorders. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.